Literature Review

Opioid use in the elderly a dementia risk factor?


 

FROM AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Interpret with caution

Commenting on the study, David Knopman, MD, a neurologist at Mayo Clinic in Rochester, Minn., whose research involves late-life cognitive disorders, was skeptical.

“On the face of it, the fact that an association was seen only in one narrow age range – 75+ to 80 years – ought to raise serious suspicion about the reliability and validity of the claim that opioid use is a risk factor for dementia, he said.

Although the researchers performed several sensitivity analyses, including accounting for mortality, “pharmacoepidemiological studies are terribly sensitive to residual biases” related to physician and patient choices related to medication use, added Dr. Knopman.

The claim that opioids are a dementia risk “should be viewed with great caution” and should not influence use of opioids where they’re truly indicated, he said.

“It would be a great pity if patients with pain requiring opioids avoid them because of fears about dementia based on the dubious relationship between age and opioid use.”

Dr. Levine and Dr. Knopman report no relevant financial disclosures.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Residential green space linked to better cognitive function
MDedge Neurology
Best antioxidants to prevent age-related dementia identified?
MDedge Neurology
Higher industriousness reduces risk of predementia syndrome in older adults
MDedge Neurology
Study casts doubt on safety, efficacy of L-serine supplementation for AD
MDedge Neurology
Neurology, psychiatry studies overlook sex as a variable
MDedge Neurology
Can fecal transplants help reverse aging? 
MDedge Neurology
Many Americans missing an opportunity to prevent dementia
MDedge Neurology
More evidence dementia not linked to PPI use in older people
MDedge Neurology
Long COVID neuropsychiatric deficits greater than expected
MDedge Neurology
Hearing, vision loss combo a colossal risk for cognitive decline
MDedge Neurology